A phase I clinical study to assess safety and immunogenicity of yellow fever vaccine

A phase I clinical study to assess safety and immunogenicity of yellow fever vaccine

Abstract Yellow fever, a mosquito-borne flavivirus infection, is an important public health problem in Africa and Latin America. A Yellow Fever vaccine (YFV) was developed and tested in a study in India. This was a Phase I, open-label, randomized, controlled study where healthy adults received SII Y...

Descrizione completa

Dettagli Bibliografici
Autori principali: Sajjad Desai, K. Anil, Anirudha Vyankatesh Potey, Y. Sindhu, Silvia Grappi, Giulia Lapini, Satyaprasad Manney, Parikshit Tyagi, Emanuele Montomoli, Cyrus S. Poonawalla, Prasad S. Kulkarni
Natura: Articolo
Lingua:English
Pubblicazione: Nature Portfolio 2022-12-01
Serie:npj Vaccines
Accesso online:https://doi.org/10.1038/s41541-022-00595-6

Accesso online

https://doi.org/10.1038/s41541-022-00595-6

Documenti analoghi